Rechallenge With BRAF and anti-EGFR Inhibitors in Patients With Metastatic Colorectal Cancer Harboring BRAFV600E Mutation Who Progressed on Cetuximab and Encorafenib With or Without Binimetinib: A Case Series
- Resource Type
- Source
- In
Clinical Colorectal Cancer September 2022 21(3):267-271 - Subject
- Language
- ISSN
- 1533-0028